1.
Albareda N, Rosenberg N, Roth S, Zsolt I, Rosen T, Hebert AA. Ozenoxacin, a Novel, Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients with Impetigo: Phase III Clinical Trials Pooled Analysis Results. J of Skin [Internet]. 2017Oct.27 [cited 2022Jun.30];1(3.1):s102. Available from: https://jofskin.org/index.php/skin/article/view/177